{"id":"https://openalex.org/W7154570845","doi":"https://doi.org/10.1177/02698811261430502","title":"Comparison of average time-to-relapse following ECT versus ketamine \u2013 A systematic review","display_name":"Comparison of average time-to-relapse following ECT versus ketamine \u2013 A systematic review","publication_year":2026,"publication_date":"2026-04-16","ids":{"openalex":"https://openalex.org/W7154570845","doi":"https://doi.org/10.1177/02698811261430502","pmid":"https://pubmed.ncbi.nlm.nih.gov/41988667"},"language":"en","primary_location":{"id":"doi:10.1177/02698811261430502","doi":"https://doi.org/10.1177/02698811261430502","is_oa":false,"landing_page_url":"https://doi.org/10.1177/02698811261430502","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Minna Chang","orcid":"https://orcid.org/0009-0007-3420-6989","observed_orcids":["https://orcid.org/0009-0007-3420-6989"]},"institutions":[{"id":"https://openalex.org/I2802518537","display_name":"Epsom and St Helier University Hospitals NHS Trust","ror":"https://ror.org/00xkqe770","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802518537"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Minna Chang","raw_affiliation_strings":["Epsom and St Helier University and Hospital Trust, London, UK"],"raw_orcid":"https://orcid.org/0009-0007-3420-6989","affiliations":[{"raw_affiliation_string":"Epsom and St Helier University and Hospital Trust, London, UK","institution_ids":["https://openalex.org/I2802518537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058414502","display_name":"Allan Hunter Young","orcid":"https://orcid.org/0000-0003-2291-6952","observed_orcids":["https://orcid.org/0000-0003-2291-6952","https://orcid.org/0000-0002-4130-5914"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Allan H. Young","raw_affiliation_strings":["Department of Brain Sciences, Imperial College, London, UK","Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Brain Sciences, Imperial College, London, UK","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002804671","display_name":"M\u00e1rio F. Juruena","orcid":"https://orcid.org/0000-0001-8558-3396","observed_orcids":["https://orcid.org/0000-0001-8558-3396"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I200323923","display_name":"South London and Maudsley NHS Foundation Trust","ror":"https://ror.org/015803449","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200323923"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mario F. Juruena","raw_affiliation_strings":["Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, UK","South London and Maudsley NHS Foundation Trust, London, UK"],"raw_orcid":"https://orcid.org/0000-0001-8558-3396","affiliations":[{"raw_affiliation_string":"Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"South London and Maudsley NHS Foundation Trust, London, UK","institution_ids":["https://openalex.org/I200323923"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2802518537"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.1561753,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"6","first_page":"900","last_page":"913"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.7490000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.7490000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.24979999661445618,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10614","display_name":"Transcranial Magnetic Stimulation Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/electroconvulsive-therapy","display_name":"electroconvulsive therapy","score":0.9300000071525574},{"id":"https://openalex.org/keywords/ketamine","display_name":"ketamine","score":0.996999979019165},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.9679999947547913},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.7250000238418579},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.6909999847412109},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.6930000185966492},{"id":"https://openalex.org/keywords/antidepressant-effects","display_name":"antidepressant effects","score":0.7509999871253967}],"concepts":[{"id":"https://openalex.org/C2780795376","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine","level":2,"score":0.7246999740600586},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6258999705314636},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5629000067710876},{"id":"https://openalex.org/C2779903281","wikidata":"https://www.wikidata.org/wiki/Q6888026","display_name":"Modalities","level":2,"score":0.4950999915599823},{"id":"https://openalex.org/C2777330709","wikidata":"https://www.wikidata.org/wiki/Q131543","display_name":"Electroconvulsive therapy","level":3,"score":0.4343999922275543},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.37880000472068787},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.353300005197525},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.31839999556541443},{"id":"https://openalex.org/C2986587452","wikidata":"https://www.wikidata.org/wiki/Q938438","display_name":"Statistical analysis","level":2,"score":0.30379998683929443},{"id":"https://openalex.org/C3020606620","wikidata":"https://www.wikidata.org/wiki/Q179661","display_name":"Treatment modality","level":2,"score":0.2476000040769577}],"mesh":[{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004565","descriptor_name":"Electroconvulsive Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004565","descriptor_name":"Electroconvulsive Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061218","descriptor_name":"Depressive Disorder, Treatment-Resistant","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D061218","descriptor_name":"Depressive Disorder, Treatment-Resistant","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D061218","descriptor_name":"Depressive Disorder, Treatment-Resistant","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D061218","descriptor_name":"Depressive Disorder, Treatment-Resistant","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/02698811261430502","doi":"https://doi.org/10.1177/02698811261430502","is_oa":false,"landing_page_url":"https://doi.org/10.1177/02698811261430502","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:41988667","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41988667","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.7468810677528381,"display_name":"Reduced inequalities","id":"https://metadata.un.org/sdg/10"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1966756094","https://openalex.org/W1969644317","https://openalex.org/W1973005276","https://openalex.org/W1997583789","https://openalex.org/W2006861654","https://openalex.org/W2016292245","https://openalex.org/W2031002884","https://openalex.org/W2036261911","https://openalex.org/W2071696563","https://openalex.org/W2091363925","https://openalex.org/W2107849028","https://openalex.org/W2109334244","https://openalex.org/W2120080550","https://openalex.org/W2123488676","https://openalex.org/W2137992068","https://openalex.org/W2146170141","https://openalex.org/W2156923987","https://openalex.org/W2180065272","https://openalex.org/W2464574439","https://openalex.org/W2613258400","https://openalex.org/W2779386549","https://openalex.org/W2802271589","https://openalex.org/W2811304329","https://openalex.org/W2950759421","https://openalex.org/W2971894339","https://openalex.org/W3019350884","https://openalex.org/W3037514201","https://openalex.org/W3088001093","https://openalex.org/W3090428067","https://openalex.org/W3148962211","https://openalex.org/W3158500235","https://openalex.org/W3207482694","https://openalex.org/W3207866042","https://openalex.org/W4206656872","https://openalex.org/W4288045936","https://openalex.org/W4317549044","https://openalex.org/W4399963461","https://openalex.org/W4406934817","https://openalex.org/W4409845273"],"related_works":[],"abstract_inverted_index":{"BACKGROUND:":[0],"Previous":[1],"systematic":[2,50,77],"reviews":[3],"and":[4,32,57,69,88,106,117,127,136,156,168,177,234],"meta-analyses":[5],"have":[6],"reported":[7],"impressive":[8],"antidepressant":[9,36],"effects":[10,37],"of":[11,34,153,170,202,210,222],"ketamine":[12,18,58,70],"in":[13,59,124,213],"treatment-resistant":[14],"depression":[15],"(TRD).":[16],"While":[17],"has":[19],"been":[20],"compared":[21],"with":[22,130,162,249],"electroconvulsive":[23],"therapy":[24],"(ECT),":[25],"the":[26,30,48,64,200,208,211],"gold":[27],"standard":[28],"treatment,":[29],"extent":[31],"durability":[33],"its":[35],"over":[38],"longer":[39,163,250],"periods":[40],"remain":[41],"unclear.":[42],"To":[43,62],"our":[44,225],"knowledge,":[45],"this":[46,76,183,191],"is":[47,147,218],"first":[49],"review":[51,78,192],"comparing":[52,245],"average":[53,65],"time-to-relapse":[54,66,231],"between":[55,67],"ECT":[56,68,155,158,233],"TRD.":[60,72],"AIMS:":[61],"compare":[63,230],"for":[71,149],"METHOD:":[73],"We":[74],"conducted":[75],"using":[79],"PubMed,":[80],"Medline,":[81],"ScienceDirect,":[82],"Cochrane":[83],"Library,":[84],"Ovid,":[85],"PsycNET,":[86],"Embase":[87],"Google":[89],"Scholar,":[90],"against":[91],"predetermined":[92],"criteria.":[93],"PROSPERO":[94],"ID:":[95],"CRD42025643824.":[96],"RESULTS:":[97],"Thirteen":[98],"studies":[99,132,194,223],"met":[100],"inclusion":[101,226],"criteria:":[102],"10":[103],"examined":[104],"ketamine/(s)ketamine,":[105],"3":[107],"focused":[108],"on":[109],"ECT.":[110],"Twelve":[111],"were":[112],"randomised":[113],"controlled":[114],"trials":[115],"(RCTs),":[116],"one":[118],"was":[119,122],"retrospective.":[120],"Heterogeneity":[121],"observed":[123],"dosing":[125],"regimens":[126],"administration":[128],"schedules,":[129],"some":[131,203],"having":[133],"limited":[134],"follow-up":[135,251],"small":[137],"sample":[138],"sizes.":[139],"Findings":[140],"are":[141,253],"synthesised":[142],"narratively.":[143],"In":[144],"summary,":[145],"there":[146],"evidence":[148],"sustained":[150],"therapeutic":[151],"potential":[152],"both":[154],"ketamine,":[157,235],"possibly":[159],"being":[160],"associated":[161],"remission.":[164],"Increased":[165],"dose,":[166],"frequency":[167],"use":[169],"maintenance":[171],"ECT/ketamine":[172],"appear":[173],"to":[174,199],"prolong":[175,182],"remission,":[176],"continuing":[178],"oral":[179],"antidepressants":[180],"may":[181],"further.":[184],"It":[185],"should":[186],"also":[187],"be":[188],"noted":[189],"that":[190,228],"excluded":[193],"involving":[195],"psychotic":[196],"depression,":[197],"leading":[198],"exclusion":[201],"head-to-head":[204],"studies,":[205],"thus":[206],"limiting":[207],"generalisability":[209],"findings":[212],"these":[214,246],"populations.":[215],"CONCLUSION:":[216],"There":[217],"currently":[219],"a":[220],"lack":[221],"within":[224],"criteria":[227],"directly":[229,244],"after":[232],"preventing":[236],"formal":[237],"statistical":[238],"analysis.":[239],"More":[240],"high-quality,":[241],"large-scale":[242],"RCTs":[243],"treatment":[247],"modalities":[248],"times":[252],"needed.":[254]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2026-04-17T00:00:00"}